Consultant Haematologist
Barts Health NHS Trust
London, England, United Kingdom
OC 30.1 - Seven-year follow-up of valoctocogene roxaparvovec gene therapy for haemophilia A
Monday, June 24, 2024
09:30 – 09:45 ICT
OC 30.2 - Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1
Monday, June 24, 2024
09:45 – 10:00 ICT
Monday, June 24, 2024
13:45 – 14:45 ICT